Anand J. C. Eijlers

Anand J. C. Eijlers

Auto-generated profile, based on publicly available information

Anand J. C. Eijlers

From the Departments of Anatomy and Neurosciences (A.J.C.E., K.A.M., L.D., J.J.G.G., M.M.S.) and Radiology and Nuclear Medicine (A.M.W.), MS Center Amsterdam, Amsterdam UMC, Locatie VUmc, Amsterdam Neuroscience, De Boelelaan 1117, PO Box 7057, 1007 MB, Amsterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2018 in Brain
Verified
Journal Article
Open access
PDF file
AEAnand J C Eijlers
Anand J C Eijlers
QGQuinten van Geest
Quinten van Geest
IDIris Dekker
Iris Dekker
MSMartijn D Steenwijk
Martijn D Steenwijk
KMKim A Meijer
Kim A Meijer
JGJeroen J G Geurts
Jeroen J G Geurts
Cognitive decline is common in multiple sclerosis and strongly affects overall quality of life. Despite the identification of cross-sectional MRI correlates of cognitive impairment, predictors of future cognitive decline remain unclear. The objective of this study was to identify which MRI measures of structural damage, demographic and/or clinical measures at baseline best predict cognitive decline, during a 5-year follow-up period. A total of 234 patients with clinically definite multiple sclerosis and 60 healthy control subjects were examined twice, with a 5-year interval (mean = 4.9 years, standard deviation = 0.9). An extensive neuropsychological evaluation was performed at both time points and the reliable change index was computed to evaluate cognitive decline. Both whole-brain and regional MRI (3 T) measures were assessed at baseline, including white matter lesion volume, diffusion-based white matter integrity, cortical and deep grey matter volume. Logistic regression analyses were performed to determine which baseline measures best predicted cognitive decline in the entire sample as well as in early relapsing-remitting (symptom duration <10 years), late relapsing-remitting (symptom duration ≥10 years) and progressive phenotypes. At baseline, patients with multiple sclerosis had a mean disease duration of 14.8 (standard deviation = 8.4) years and 96/234 patients (41%) were classified as cognitively impaired. A total of 66/234 patients (28%) demonstrated cognitive decline during follow-up, with higher frequencies in progressive compared to relapsing-remitting patients: 18/33 secondary progressive patients (55%), 10/19 primary progressive patients (53%) and 38/182 relapsing-remitting patients (21%). A prediction model that included only whole-brain MRI measures (Nagelkerke R2 = 0.22, P < 0.001) showed cortical grey matter volume as the only significant MRI predictor of cognitive decline, while a prediction model that assessed regional MRI measures (Nagelkerke R2 = 0.35, P < 0.001) indicated integrity loss of the anterior thalamic radiation, lesions in the superior longitudinal fasciculus and temporal atrophy as significant MRI predictors for cognitive decline. Disease stage specific regressions showed that cognitive decline in early relapsing-remitting multiple sclerosis was predicted by white matter integrity damage, while cognitive decline in late relapsing-remitting and progressive multiple sclerosis was predicted by cortical atrophy. These results indicate that patients with more severe structural damage at baseline, and especially cortical atrophy, are more prone to suffer from cognitive decline. New studies now need to further elucidate the underlying mechanisms leading to cortical atrophy, evaluate the value of including cortical atrophy as a possible outcome marker in clinical trials as well as study its potential use in individual patient management.

7 March 2017 in Neurology
Verified
Journal Article
Closed access
PDF file
AEAnand J.C. Eijlers
Anand J.C. Eijlers
KMKim A. Meijer
Kim A. Meijer
TWThomas M. Wassenaar
Thomas M. Wassenaar
MSMartijn D. Steenwijk
Martijn D. Steenwijk
BUBernard M.J. Uitdehaag
Bernard M.J. Uitdehaag
MSMenno M. Schoonheim
Menno M. Schoonheim
Objective: To investigate how changes in functional network hierarchy determine cognitive impairment in multiple sclerosis (MS). Methods: A cohort consisting of 332 patients with MS (age 48.1 ± 11.0 years, symptom duration 14.6 ± 8.4 years) and 96 healthy controls (HCs; age 45.9 ± 10.4 years) underwent structural MRI, fMRI, and extensive neuropsychological testing. Patients were divided into 3 groups: cognitively impaired (CI; n = 87), mildly cognitively impaired (MCI; n = 65), and cognitively preserved (CP; n = 180). The functional importance of brain regions was quantified with degree centrality, the average strength of the functional connections of a brain region with the rest of the brain, and eigenvector centrality, which adds to this concept by adding additional weight to connections with brain hubs because these are known to be especially important. Centrality values were calculated for each gray matter voxel based on resting-state fMRI data, registered to standard space. Group differences were assessed with a cluster-wise permutation-based method corrected for age, sex, and education. Results: CI patients demonstrated widespread centrality increases compared to both HCs and CP patients, mainly in regions making up the default-mode network. Centrality decreases were similar in all patient groups compared to HCs, mainly in occipital and sensorimotor areas. Results were robust across centrality measures. Conclusions: Patients with MS with cognitive impairment show hallmark alterations in functional network hierarchy with increased relative importance (centrality) of the default-mode network.

1 August 2019 in Radiology
Verified
Journal Article
Closed access
AEAnand J. C. Eijlers
Anand J. C. Eijlers
AWAlle Meije Wink
Alle Meije Wink
KMKim A. Meijer
Kim A. Meijer
LDLinda Douw
Linda Douw
JGJeroen J. G. Geurts
Jeroen J. G. Geurts
MSMenno M. Schoonheim
Menno M. Schoonheim
Cognitively impaired patients with multiple sclerosis demonstrate markedly reduced network dynamics in default-mode, frontoparietal, and visual networks as well as an almost complete loss in the no... Background Previous studies have demonstrated extensive functional network disturbances in patients with multiple sclerosis (MS), showing a less efficient brain network. Recent studies indicate tha...

1 October 2019 in Neurology
Verified
Journal Article
Closed access
PDF file
AEAnand J.C. Eijlers
Anand J.C. Eijlers
IDIris Dekker
Iris Dekker
MSMartijn D. Steenwijk
Martijn D. Steenwijk
KMKim A. Meijer
Kim A. Meijer
HHHanneke Hulst
Hanneke Hulst
JGJeroen J.G. Geurts
Jeroen J.G. Geurts
Objective To determine which pathologic process could be responsible for the acceleration of cognitive decline during the course of multiple sclerosis (MS), using longitudinal structural MRI, which was related to cognitive decline in relapsing-remitting MS (RRMS) and progressive MS (PMS). Methods A prospective cohort of 230 patients with MS (179 RRMS and 51 PMS) and 59 healthy controls was evaluated twice with 5-year (mean 4.9, SD 0.94) interval during which 22 patients with RRMS converted to PMS. Annual rates of cortical and deep gray matter atrophy as well as lesion volume increase were computed on longitudinal (3T) MRI data and correlated to the annual rate of cognitive decline as measured using an extensive cognitive evaluation at both time points. Results The deep gray matter atrophy rate did not differ between PMS and RRMS (−0.82%/year vs −0.71%/year, p = 0.11), while faster cortical atrophy was observed in PMS (−0.87%/year vs −0.48%/year, p < 0.01). Similarly, faster cognitive decline was observed in PMS compared to RRMS (p < 0.01). Annual cognitive decline was related to the rate of annual lesion volume increase in stable RRMS (r = −0.17, p = 0.03) to the rate of annual deep gray matter atrophy in converting RRMS (r = 0.50, p = 0.02) and annual cortical atrophy in PMS (r = 0.35, p = 0.01). Conclusions These results indicate that cortical atrophy and cognitive decline accelerate together during the course of MS. Substrates of cognitive decline shifted from worsening lesional pathology in stable RRMS to deep gray matter atrophy in converting RRMS and to accelerated cortical atrophy in PMS only.

1 August 2018 in Radiology
Verified
Journal Article
Closed access
AEAnand J. C. Eijlers
Anand J. C. Eijlers
KMKim A. Meijer
Kim A. Meijer
QGQuinten van Geest
Quinten van Geest
JGJeroen J. G. Geurts
Jeroen J. G. Geurts
MSMenno M. Schoonheim
Menno M. Schoonheim
Patients with multiple sclerosis and gray matter atrophy have cognitive impairment related to white matter damage; however, in patients without atrophy, cognitive impairment was primarily determined by cognitive reserve (ie, low level of education). Abnormalities depicted with functional MRI could serve as a marker of cognitive impairment, independent of atrophy. Purpose To investigate the discrepancy between patients with multiple sclerosis (MS) without atrophy who have already developed cognitive impairment and patients with MS with atrophy who have preserved cognitive function. Materials and Methods This retrospective imaging study, with imaging acquired between 2008 and 2012, included 332 patients with MS (106 men and 226 women; mean age, 48.1 years; range, 23.0–72.5 years) and 96 healthy control participants. Cognitive impairment was defined as cognitive performance of z less than −1.5 compared with that in control participants in greater than or equal to two cognitive domains. Atrophy was defined as cortical and deep gray matter volumes of z less than −1.5 compared with that in control participants. White matter lesions were assessed with T2-imaging, tract fractional anisotropy (ie, integrity) with diffusion MRI, and regional centrality (ie, importance within network) with functional MRI. Within each atrophy group, patients with cognitive impairment and pres...

1 January 2021 in NeuroImage: Clinical
Verified
Journal Article
Open access
IDIris Dekker
Iris Dekker
MSMenno M. Schoonheim
Menno M. Schoonheim
VVVikram Venkatraghavan
Vikram Venkatraghavan
AEAnand J.C. Eijlers
Anand J.C. Eijlers
IBIman Brouwer
Iman Brouwer
VWViktor Wottschel
Viktor Wottschel
As disease progression remains poorly understood in multiple sclerosis (MS), we aim to investigate the sequence in which different disease milestones occur using a novel data-driven approach. We analysed a cohort of 295 relapse-onset MS patients and 96 healthy controls, and considered 28 features, capturing information on T2-lesion load, regional brain and spinal cord volumes, resting-state functional centrality ("hubness"), microstructural tissue integrity of major white matter (WM) tracts and performance on multiple cognitive tests. We used a discriminative event-based model to estimate the sequence of biomarker abnormality in MS progression in general, as well as specific models for worsening physical disability and cognitive impairment. We demonstrated that grey matter (GM) atrophy of the cerebellum, thalamus, and changes in corticospinal tracts are early events in MS pathology, whereas other WM tracts as well as the cognitive domains of working memory, attention, and executive function are consistently late events. The models for disability and cognition show early functional changes of the default-mode network and earlier changes in spinal cord volume compared to the general MS population. Overall, GM atrophy seems crucial due to its early involvement in the disease course, whereas WM tract integrity appears to be affected relatively late despite the early onset of WM lesions. Data-driven modelling revealed the relative occurrence of both imaging and non-imaging events as MS progresses, providing insights into disease propagation mechanisms, and allowing fine-grained staging of patients for monitoring purposes.